ENTPD1 and non-small cell lung carcinoma: To this regard, an interesting hallmark of NSCLC-harboring oncogenic driver mutations, leading to immune escape, and conferring primary immune resistance, is the reprogramming of energy metabolism mediated by CD39/CD73—adenosine signaling.